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Background: Diabetes is increasingly becoming a major health problem in Jordan and glycemic goals are
often not achieved.
Objective: To explore the patients’ perspectives regarding type 2 diabetes and its management in order to
‘‘fine-tune” future pharmaceutical care intervention programs.
Method: Focus groups method was used to explore views from individuals with type 2 diabetes attending
outpatient diabetes clinic at the Royal Medical Services Hospital. All interviews were recorded,
transcribed and analyzed using a thematic analysis approach.
Results: A total of 6 focus groups, with 6 participants in each one, were conducted. Participants in the pre-
sent study demonstrated a great information needs about diabetes and the prescribed treatment.
Medication regimen characteristics including rout of administration, number of prescribed medications
and dosage frequency in addition to perceived side effects represented the major barriers to medication
adherence. In addition to demonstrating negative beliefs about the illness and the prescribed medica-
tions, participants showed negative attitudes and low self-efficacy to adhere to necessary self-care
activities including diet, physical activity and self-monitoring of blood glucose.
Conclusion: Future pharmaceutical care interventions designed to improve patients’ adherence and
health outcomes in patients with type 2 diabetes should consider improving patients’ understanding
of type 2 diabetes and its management, simplifying dosage regimen, improving patient’s beliefs and
attitudes toward type 2 diabetes, prescribed medications and different self-care activities in addition
to improving patient’s self efficacy to perform different treatment recommendations.
 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Diabetes is a major public health concern and financial burden
all over the world. The prevalence of diabetes is dramatically
increasing globally (Wild et al., 2004), particularly in developing
countries including Jordan (Ajlouni et al., 1998). Compared to108 million people affected by diabetes in 1980, an estimated
422 million adults were found to have diabetes in 2014 (WHO,
2016). The World Health Organization (WHO) data indicates an
increase from 1% in 2002 to 7% in 2010 (WHO, 2011) in the propor-
tion of diabetes-related deaths in Jordan. Uncontrolled diabetes
leads to long-termmicrovascular and macrovascular complications
including retinopathy, nephropathy, neuropathy and cardiovascu-
lar diseases (Kelly and Rodgers, 2000).
Patients’ non-adherence to therapeutic regimens and lifestyle
advice is a major barrier to achieve the desired glycemic control
in order to prevent diabetes related complications (McDonald
et al., 2002; Irons et al., 2002). Available data indicates that
improving treatment adherence leads to improved clinical out-
comes (Rhee et al., 2005). However, information available on treat-
ment adherence in patients with type 2 diabetes is sparse despite
its importance (Cramer, 2004). In a study conducted in Jordan, it
was found that of the 171 study participants, almost three quarter
(72.5%) were classified as non-adherent (Jarab et al., 2014). Factors
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been assessed in different studies, but the patients’ perspective
and participation in the treatment decisions and care plan design
was remarkably absent (Vermeire et al., 2003). Clarke et al.
reported that it is very important to have a patient-centered
approach because it is estimated that patients with diabetes are
responsible for 95% of their own management and one of the rea-
sons for poor outcomes of diabetes treatments is lack of patients’
participation (Clarke et al., 2002). In order to achieve better adher-
ence to prescribed treatment, healthcare professionals need to
understand and address factors that enable patients to adhere
(Gagliardino and Etchegoyen, 2001). Vermeire et al. reported that
the first step to designing effective interventions is to understand
those factors that help patients with type 2 diabetes adhere to
therapeutic regimens and lifestyle advice (Vermeire et al., 2003).
Furthermore, little is known about the barriers that people with
diabetes face to incorporate self-care activities into their lifestyles
(Nagelkerk et al., 2006).
Qualitative research, including focus group method, enables us
to access areas not amenable to quantitative methodology and
allows for the introduction of new issues and ideas necessary for
the development of effective interventions (Haines and Jones,
1994). In addition to the enhancement of the participation of peo-
ple who cannot read or write (Kitzinger, 1995), focus group can
help the participants exploring their views in a more accessible
way than other qualitative research methods such as one-to-one
interview (Kitzinger, 2000). Qualitative research in the form of
focus group method was chosen in the present study to obtain
an in-depth exploration of the patient’s perceptions and views in
managing type 2 diabetes. There is limited information in the liter-
ature on what diabetic patients feel and think in relation to treat-
ment adherence (Vermeire et al., 2003; Benner, 1985). This study,
to our knowledge, is the first one that has examined patients’ expe-
riences of type 2 diabetes in Jordan. The current study findings
should be incorporated into future diabetes care programs which
are tailored to patients’ needs and designed to improve health
outcomes in patients with type 2 diabetes.2. Aim of the study
To explore the patients’ perspectives and experiences of type 2
diabetes and its management, in addition to their views about the
barriers to adherence to medications and self-care activities. Find-
ings should be useful in the design of future pharmaceutical care
interventions aiming at improving health outcomes in patients
with type 2 diabetes.3. Methods
3.1. Study site and subjects
Patients attending the outpatient diabetes clinic at the Royal
Medical Services Hospital who met the inclusion criteria were pro-
vided with an information sheet and asked to sign a consent form if
they agreed to participate in the study. All patients who had type 2
diabetes for at least one year and took at least one medication for
diabetes control were included in the study. Patients were
excluded if they suffered from mental or physical disability.
3.2. Study design
A qualitative research approach i.e. focus group discussions,
was adopted in the present research. The focus group discussion
was guided by the principal investigator (AJ) with the assistance
of (TM), who have a good experience in caring for patients withtype 2 diabetes, using a schedule of open-ended questions
designed to explore information needs about diabetes and its treat-
ment and barriers to adherence to prescribed medications and dif-
ferent self-care activities as shown in Table 1. The researchers did
not have a previous relation with any of the study participants and
they were not working in the clinic at which the current study was
conducted. Before conducting each focus group, participants were
informed that the discussion would be recorded and remain confi-
dential. All focus groups were conducted in Arabic with an average
time of 75 minutes for each focus group. AJ demonstrated that the
purpose of the research was to gain a better understanding of how
they, as patients, understand and cope with diabetes and its man-
agement. Typically, 6–8 people are recruited in each group to
explore patient experiences of disease and health issues. Based
on purposive sampling technique, the process of adding focus
groups was carried out until no new information can been attained
and theoretical data saturation was reached (Glaser and Strauss,
1967). Accordingly, a total of 6 focus groups with a total of 36
patients were used in the current study.3.3. Data analysis
The audiotapes from the focus groups were transcribed verba-
tim and the transcripts were checked for accuracy against the orig-
inal audiotapes (Boeije, 2002). Transcripts were translated into
English and then back translated to Arabic by two independent
translators to guarantee content consistency. Each transcript was
coded independently by three members of the research team.
The data were analyzed using a thematic analysis approach
(Kitzinger, 2000; Silverman, 1993). Transcripts of each individual
focus group were read, re-read and summary notes were made.
Topics raised were grouped under potential thematic categories,
which were often renamed, when a more appropriate title
emerged. The ideas and issues, which emerged, were grouped into
categories and then further grouped into themes. Having carried
out this exercise independently, the team members met to discuss
and agree a final framework to describe and evaluate the informa-
tion and views brought forward by the patients.4. Results
Six focus groups were held with a total of 36 patients. The
demographic characteristics of the participants are shown in
Table 2. The participants demonstrated a variation among each
focus group in relation to gender, age, employment status, disease
duration, compelling indications and disease severity. The analysis
resulted in the following major themes: knowledge and informa-
tion needs about diabetes and its management, barriers to adher-
ence to medications and self-care activities, and self-efficacy and
beliefs about illness and medications.
Theme 1 Knowledge and information needs
Knowledge about diabetes
Participants demonstrated little knowledge about type 2
diabetes
‘‘Is it the food that we are eating that causes diabetes or is it obe-
sity?” (P15)
‘‘Is it something to do with your pancreas?” (P22)
‘‘. . .is it something to do with the genes?” (P28)
On the other hand, better knowledge and awareness was
demonstrated about poor blood glucose control
‘‘There is a poster here somewhere which says that 75% of people
with diabetes die of a heart condition” (P8)
‘‘Diabetes can cause nerve damage and sometimes patients require
foot amputation as blood vessels can be damaged and there can be
kidney damage” (P15)
Table 1
Open-ended questions used during focus groups interview.
Question 1: What do you know about type 2 diabetes?
Question 2: Why it is important to control blood sugar? How has diabetes affected your health?
Question 3: What type of medications you take to control your blood sugar?
Question 4: How would your medications help you to control your blood sugar?
Question 5: What do you expect from your medications?
Question 6: What makes taking your medications as prescribed difficult?
Question 7: How can you help the medical team to control your blood sugar?
Question 8: How does having diabetes impact your daily life?
Table 2
Characteristics of the participants in the six focus groups (n = 36).
Characteristics FG1 FG2 FG3 FG4 FG5 FG6 n %
Gender
Male 4 4 4 5 4 5 26 72.2
Female 2 2 2 1 2 1 10 27.8
Age
30–40 1 2 1 1 0 1 6 16.7
41–50 1 2 1 2 2 1 9 25
51–60 2 2 2 1 2 2 11 30.6
61–70 2 0 1 2 2 1 8 22.2
>70 0 0 1 0 0 1 2 5.5
Employment status
Working 3 5 4 4 4 4 24 66.6
Retired 3 1 2 2 2 2 12 33.3
Duration of diabetes (years)
<5 2 1 1 1 1 1 7 19.4
5–9 2 3 1 2 2 2 12 33.3
10–15 1 1 1 1 2 3 9 25
>15 1 1 3 2 1 0 8 22.2
Diabetes pharmacotherapy
Oral tablets only 2 3 4 2 4 3 18 50
Insulin injections only 1 1 1 2 0 1 6 16.7
Oral tablets and insulin injections 3 2 1 2 2 2 12 33.3
FG: focus group.
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loss of feeling in the feet.” (P17)
Knowledge about the medications
The patients expressed a range of information needs related to
medication regimens including: type, therapeutic effect, potential
side effects and dosing of the prescribed medications
‘‘How many types of tablets are there?” (P11)
‘‘Are they of different strengths? What do the medications do for
you?” (P17)
‘‘I don’t know when to take my medicines, I just swallow them”
(P5)
‘‘They work and they do help you to reduce your glucose levels but
the side effects are not explained to you and I think the combination of
oral tablets also made my mood swings bad” (P3)
‘‘I think it should be explained more to you when is the best time to
take your individual tablets” (P20)
The patients in the focus groups highlighted the need to under-
stand the rationale behind the prescribed treatment i.e. some
patients are prescribed lifestyle change while others need
medications.
‘‘I don’t understand that. Some people are just on diet and others
are on insulin” (P24)
Theme 2 Barriers to adherence to medications
In addition to poor knowledge, therapeutic regimen characteris-
tics constituted a major barrier to medication adherence for the
study participants. Focus group participants in the present study
showed many concerns regarding insulin injection and would have
preferred a non parenteral route of administration. Many patients
related the reason for non-adherence to the high number of the
prescribed medications and the multiple dosing frequencies, whileothers related non-adherence to the sideeffects of the prescribed
medications.
Route of administration
‘‘I would almost prefer it if it wasn’t for the needle. If there was
another way of taking it” (P35)
Frequency of administration
‘‘This is where we are ignorant. I have to take some in the morning
and some in the evening but you are saying take one daily dose” (P4)
‘‘If it could be made that you could take all your medicines in one
go that would be better than having different periods”.
Polypharmacy
‘‘At the end of the day I feel I am taking so many tablets” (P19)
However, other participants gave important suggestions to help
in taking prescribed medications as recommended
‘‘I put mine in a box Monday, Tuesday and Wednesday etc. and
then I know that I have taken them if they are empty” (P9)
‘‘I sit down and do my tablets for a week and then I know what I am
running short of and I order them on a Monday” (P21)
‘‘I take mine from a medical box and they are all set out” (P26)
Theme 3 Self-efficacy
Some patients exhibited high self-efficacy by emphasizing the
importance of individual responsibility to follow the treatment
recommendations and to achieve the desired clinical outcomes
‘‘It is also about taking responsibility for your own health. You go to
the doctor or the nurse and they tell you what to do but in reality the
health service is getting to the stage where you are going to have to
take responsibility for your own health” (P1)
‘‘It’s up to yourself if you take your medication or not” (P33)
However, the patients in general showed low self-efficacy in
following the different aspects of lifestyle advice and self-care
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glucose.
‘‘I would need someone to nearly come and do it for me because I
would only monitor my blood sugars about 3 times a week” (P7)
‘‘It is very difficult to control what you eat. You more or less have to
set your limits and that is where the people round you come in and
that can encourage you to eat even more.
‘‘I find I am too tired to do exercise. I can’t motivate myself” (P22)
‘‘Once I sit down that is it‘‘(P23)
Theme 4 Health beliefs
Beliefs about illness
Participants showed negative illness beliefs illustrated by nega-
tive attitudes to the illness and the impact of diabetes on their
daily life
‘‘It is endless, you have it for the rest of your life, and it does not go
away” (P4)
‘‘I know that it does progress no matter what you do” (P14)
‘‘It means your life is governed by other people who say to do this
and do that” (P23)
‘‘But it can be very depressing. I am on tablets for depression” (P29)
Beliefs about medications
Patients’ concerns about diabetes medications varied. This
included concerns about side effects of the medications, lack of
confidence in the effectiveness of diabetes medications and fears
from insulin injections
‘‘I am concerned about them because when you take a cocktail of
about 20 tablets a day and according to the manufacturer each one
has the potential for so many side-effects” (P11)
‘‘I would prefer not to have to take medication. I would try to con-
trol it with diet and exercise” (P32)
‘‘It is the night mare; it is the injection” (P23)5. Discussion
The focus group interviews, which are discussed in the current
study, represent qualitative researchmethod that is based on group
interactions to develop and refine interventions via exploring
patients’ experiences of disease and health issues (Vermeire et al.,
2001). In a focus group, participants are encouraged to exchange
information on each others experiences and points of view, talking
to each other, asking questions and listening to what others say,
which help them articulate their own issues (Kitzinger, 1994).
The rationale is that under the guidance of a focus group leader,
group members can describe the reasoning behind their actions,
perceptions, beliefs and attitudes in ways that would be less easily
accessible in a one-to-one interview (Farmer et al., 2005).
The results of the present study show that knowledge deficit,
together with the therapeutic regimen complexity, made it very
difficult for patients to adhere to the prescribed therapy. Consis-
tent with the findings of others (Vermeire et al., 2003; Vinter-
Repalust et al., 2004), participants in the present study demon-
strated a poor knowledge and significant information needs about
type 2 diabetes and its management. Coates et al. found that lack of
knowledge was one of the reasons why patients do not manage
their diabetes effectively (Coates and Boore, 1996). A recent focus
group study showed unmet information needs among Australian
patients with type 2 diabetes (Carolan et al., 2015). Although
behavioral change and effective self-management is not guaran-
teed by knowledge alone, the assessment of diabetes-related
knowledge is an important first step from which to individualize
diabetes education programs and make evaluations of their effec-
tiveness (Garcia et al. (2001); Nau and Ponte (2001)).
Consistent with the current study findings, research has also
clearly indicated that polytherapy regimens (Donnan et al., 2002;
Melikian et al., 2002), perceived adverse effects (Melikian et al.,2002; Grant et al., 2003; Islam et al., 2017), higher dosing fre-
quency (Paes et al., 1997; Rubin, 2005), and receiving insulin
(Cramer, 2004; Vermeire et al., 2003; Jarab et al., 2014; Lerman,
2005) have a negative impact on medication adherence in diabetic
patients. In a study of 18 focus groups conducted by Hayes et al.,
type 2 diabetes patients were concerned about the inconvenience
which results from frequent dosing requirements, which in turn
leads to missed doses (Hayes et al., 2006). They suggested a sus-
tained release tablet so that they can take their medication once
daily. The patients also demonstrated a desire to avoid insulin
injection and polypharmacy. The complicated therapeutic regimen
has been identified as a barrier to medication adherence in a focus
group of pregnant Zimbabwean women (Mukona et al., 2017). All
these findings are consistent with the present research results.
Many participants in the present study demonstrated low self-
efficacy. Research has indicated that self-efficacy is an important
predictor of a range of health behaviors including adherence with
the prescribed medications in a variety of chronic conditions such
as diabetes (Littlefield et al., 1992). Research has also indicated that
it is generally much more difficult to achieve and maintain adher-
ence with lifestyle regimens than with prescribed medications
(Poirier et al., 2006). As demonstrated in the present study, nega-
tive attitudes to different aspects of self-care activities, combined
with low self-efficacy, were dominant factors affecting adherence
to lifestyle advice and self-care activities. Self-efficacy has been
found to predict adherence with diet recommendations (Sarkar
et al., 2006), exercise regimens and self-monitoring of blood glu-
cose (Horne and Weinman, 1999). Another recent focus group
study emphasized on the importance of improving self-efficacy
among patients with type 2 diabetes in Germany (Grammes, 2017).
Qualitative studies have also indicated that health beliefs are
important predictors of adherence to therapeutic regimens
(Vermeire et al., 2003; Vinter-Repalust et al., 2004). Patients in this
study demonstrated negative beliefs about their illness and their
medications, both of which have been suggested as strong predic-
tors of medication non-adherence (Vermeire et al., 2003; Jarab
et al., 2012).
In summary, the current explorative study findings should pro-
vide useful to determine the elements of future effective and speci-
fic pharmaceutical care programs designed to improve blood
glucose control and other clinical and humanistic outcomes in
patients with type 2 diabetes.6. Conclusions
The patients generally demonstrated poor knowledge about
type 2 diabetes which may influence their approach to their dis-
ease management. The patients also demonstrated clear informa-
tion needs relating to the prescribed medications including:
effect, dosing, potential side effects and the time required to
achieve the desired blood glucose control. Meeting these informa-
tion needs via individualized patients educational programs should
be considered by future effective pharmaceutical care interven-
tions. It was apparent from concerns regarding dosing frequency,
and the number of drugs being prescribed for some patients, that
medication regimen should be rationalized where possible. Insulin
injection was not a popular treatment choice. The study also
revealed that patients had negative beliefs about their medications,
represented by concerns about the effectiveness of the prescribed
medications. Much concern about the possible sideeffects of the
medications was demonstrated by the patients. Such concerns
have been reported in the literature to influence patients’ adher-
ence to medications and therefore need to be addressed. Although
some patients demonstrated positive illness beliefs of the aware-
ness of the disease severity and the susceptibility to develop com-
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negative illness beliefs and attitudes. Such concerns and beliefs
should again be addressed in future intervention programs. Adher-
ence to lifestyle advice was influenced by negative attitudes to life-
style change, lack of awareness about the importance of different
elements of lifestyle advice and low self-efficacy. These barriers
provide a target for future diabetes care programs.
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Final themes were not validated by the participants and the
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